President, Co-Founder & Board Director — Thomas Forest Farb

Serial life sciences & technology entrepreneur at Cytyc, Indevus Pharmaceuticals, Interneuron Pharmaceuticals, MedicaMetrix & Trust for Science & Technology. (email LinkedIn Profile

CSO, Co-Founder & Board Director — Alan Blanchard, Ph.D.

Numerous commercial instrumentation successes in DNA sequencing & DNA microarrays at Life Technologies, Applied Biosystems, Agencourt Personal Genomics & Rosetta Inpharmatics. B.S. & Ph.D., California Institute of Technology & postdoctoral fellowship with Lee Hood. Seven issued patents. (email LinkedIn Profile

VP of Collaborations — Derek Brand

Senior management roles at Quicksilver Biosystems and Marvel Genomics. Business development roles at Enumeral Biomedical, Hypermed and New York Academy of Sciences. Research Scientist at Argose.  (email LinkedIn Profile

General Counsel — Christian LaPointe, Ph.D., J.D.

General Counsel at ArcherDX, Enzymatics, Axios, Aramark. Senior Patent Manager, Dana Farber Cancer Institute, Testa Hurwitz & Thibeault. Ph.D., Dartmouth, Biochemistry. (email LinkedIn Profile

VP of Engineering & Manufacturing — John Luckey, Ph.D. M.B.A.

Senior management and product development roles at RainDance Technologies (acquired by Bio-Rad), PathoGenetix, Roche NimbleGen, OpGen Technologies, MJ Research (acquired by Bio-Rad), Founder and CSO at GeneSys Technologies (acquired by MJ Research). Ph.D., Chemisty, and M.B.A., University of Wisconsin; 3 patents. (email john.luckey@thrivebio.comLinkedIn Profile

Outside Board of Directors

Guy Broadbent, Chairperson

President, Vector Advisorys. Previously CEO, Argotec; President, Thermo Fisher Scientific, Laboratory Products Group; CEO, XcellerX (acquired by GE); Chairperson at Aquapak Polymers. Member of Board of Directors at Paragon Films, Aurora Plastics, Sample6 Technologies, Blue Sky Biotech & Galius BioPharmaceuticals. LinkedIn Profile 

Michael Finney, Ph.D., Director

Managing Director, Finney Capital; Previously Co-founder & CSO, MJ Research; CEO, Vaxart; Member of Board of Directors at Genome Partnership, Innerscope Research, Orion Genomics, Sage Science & Vaxart. Ph.D., Massachusetts Institute of Technology, Biology.  LinkedIn Profile

Brock C. Reeve, M.Phil., M.B.A., Director

Executive Director of Harvard Stem Cell Institute; Previously Managing Director & COO of Life Science Insights, an IDC company; Healthcare Practice Director of Viant Corp.; Principal of SRI Consulting. M.Phil, Yale; MBA, Harvard Business School.  LinkedIn Profile

Advisory Board

Stephen Fantone, Ph.D. (Optics)

  • Founder & CEO, Optikos Corporation
  • Director, American Optical Society
  • MIT, University of Rochester (Ph.D.)

Mariano Garcia-Blanco, M.D., Ph.D. (Biology)

  • Prof & Chair, Biochemistry & Molecular Biology, U of Texas Medical Branch
  • Prof, Duke-NUS Med School, Singapore
  • Yale (M.D. & Ph.D.)

Guy Fish, M.D., M.B.A. (Strategy & Market Research)

  • VP, Health Practices Group, Fletcher Spaght
  • VP, Business Development & International, Collagenesis
  • Yale (M.D., M.B.A.)

Anna Kushnir, Ph.D. (Government Grants / Policy)

  • VP, Life Sciences, Strategic Marketing Innovations
  • Harvard Medical School (Ph.D.)

James Kurnick, M.D. (Cancer, Drug Development)

  • President, Cytocure, Tribiotica
  • Harvard Medical School (M.D.)

Stan Lapidus (Diagnostics)

  • Founder & CEO of SynapDx, Helicos, Exact Labs, Cytyc
  • Cooper Union

Gaël McGill, Ph.D. (Cell Biology, Software)

  • Founder & CEO, Digizyme
  • Director of Molecular Visualization, Harvard Med
  • Swarthmore, Harvard Medical School (Ph.D.)

James Sherley, M.D., Ph.D. (Stem Cells)

  • Founder, Asymmetrex
  • Former Director, Adult Stem Cell Technology Center
  • Johns Hopkins Medical School (M.D., Ph.D.)

Jesus Soriano, M.D., Ph.D., MBA (Business Development)

  • Program Director, National Science Foundation
  • Head of Business Development: Osiris, ATCC & EntreMed
  • University of Geneva Med (M.D., Ph.D.), Johns Hopkins (M.B.A.)